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H I G H L I G H T S
• Addicts experience a relationship between substance use and sexual behavior
• About ten percent state that sexual thoughts and feelings causes craving
• A quarter of the patients link sexual thoughts, feelings and behaviors to drug use
• GHB-users perceive most enhancements in sexual functioning
• Users of alcohol are sexually less active than users of other substances







A B S T R A C T
Introduction: Hardly any research exists on the relationship between substance use and sexual behaviors in
patients with a substance use disorder. This study aimed to examine this relation by looking into perceived
positive eﬀects on sexual behavior, perceived negative eﬀects and risky sexual behavior due to substance use in
patient groups of users of alcohol, stimulants, sedatives and Gamma hydroxybutyrate (GHB). In addition, the
current study aimed to address the question whether sexual behavior (e.g. number of sexual partners, sexual
activity) diﬀers between these patient groups.
Method: A total of 180 patients with a substance use disorder (i.e. alcohol, amphetamine, cannabis, cocaine,
GHB and opiates) participated. A self-report questionnaire was administered with questions on substance use,
sexual behaviors (e.g. sexual activity, masturbation, use of pornography) and statements about the perceived
changes in sexual functioning and behavior under inﬂuence of the primary substance of abuse.
Results: All four groups reported changes in sexual thoughts, feelings and behavior due to the use of their
primary substance. More than half of the patients reported enhancements in sexual domains (i.e. sexual pleasure,
sexual arousal, sexual behavior), but also decrements or risky behaviors and about a quarter stated that their
sexual thoughts, feelings and behaviors were often associated with the use of their primary substance of abuse.
Patients with a GHB use disorder reported the strongest relation between drug use and sexual behavior. Users of
GHB not only reported more enhancement in several sexual domains, but also less decline in sexual domains
compared to the other patient groups and more risky behavior or more sexual activity than some of the other
groups of patients.
Conclusions: The results underline the importance of addressing the relationship between substance use and
sexual behavior in treatment programs, as patients may be hesitant to stop their use of substances when they
experience many positive eﬀects in their sexual behavior. Future research directions are suggested.
1. Introduction
A lot has been written about sexual behavior and substance use, but
hardly any research exists about the eﬀects of the use of substances on
sexual behavior of patients with a substance use disorder. Concerning
sexual behavior and substance use disorders in non-patient samples the
focus has primarily been on risky sexual behavior (Buﬀum, 1988;
Celentano, Latimore, & Mehta, 2008; Zapata, Hillis, Marchbanks,
Curtis, & Lowry, 2008). Drug users have consistently been identiﬁed as
a population with elevated infection rates of sexual transmitted
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infections, including HIV (Adrian, 2009; Celentano et al., 2008; Khan
et al., 2013; Maranda, Han, & Rainone, 2004; Zapata et al., 2008), but
less clear is whether this can be attributed to the eﬀects of the substance
alone (Celentano et al., 2008; Khan et al., 2013; Kopetz, Reynolds, Hart,
Kruglanski, & Lejuez, 2010; Rawson, Washton, Domier, & Reiber,
2002). Several studies found that the use of crack-cocaine is associated
with higher levels of risk taking sexual behavior (e.g. elevations in
numbers of sex partners and sex trade, decreased use of condoms) than
is the use of other drugs such as opiates (Celentano et al., 2008; Khan
et al., 2013; Lejuez, Bornovalova, Daughters, & Curtin, 2005), but these
diﬀerences may also be explained by other factors that may contribute
to ﬂuctuations in risky sexual behavior in patients with a substance use
disorder, such as gender, sexual orientation, race and social context
(Celentano et al., 2008; Kopetz et al., 2010). Nonetheless, it appears
that the use of certain drugs, especially crack-cocaine, is associated with
risky sexual behavior and that the use of other drugs, such as opiates, is
either not associated or less associated with such behavior.
With regard to non-risky sexual functioning and behavior it has
been found in non-patient samples that small amounts of alcohol and
cannabis can enhance sexual arousal and performance, but also that
high doses can inhibit sexual functioning (Gianotten, 2009; Miller &
Gold, 1988; Washton & Zweben, 2006). In 2015 Eaton et al. estimated
that 4.3 million American adults annually engage in regularly sex-re-
lated alcohol consumption (i.e. drink alcohol before sex). Although
alcohol is a central nervous system depressant that slows down several
body systems and suppresses the sexual physiology, thereby inhibiting
sexual functioning (Peugh & Belenko, 2001; Stoeckhart, Swaab, Gijs, de
Ronde, & Slob, 2009), it had been found that the anticipated eﬀect of
alcohol can enhance sexual desire (George & Stoner, 2000; McKay,
2005; Peugh & Belenko, 2001). Thus, there is a relationship between
alcohol use and sexuality, but this relation appears to be complex. In
addition, a recent study found marijuana use to be associated with in-
creased sexual frequency while it did not appear to impair sexual
function (Sun & Eisenberg, 2017). Similarly, cocaine has been found to
delay orgasm and to enhance sexual pleasure and arousal on the one
hand, but also to be associated with erectile dysfunction on the other
hand (Gianotten, 2009; Peugh & Belenko, 2001). In addition, studies
have found that chronic use of cocaine diminishes sexual desire and
hampers orgasm (Peugh & Belenko, 2001; Weatherby et al., 1992).
Furthermore, the drug Gamma Hydroxybutyrate (GHB) is well known
for enhancing sexual arousal (Nicholson & Balster, 2001). These ﬁnd-
ings show that the use of substances can have eﬀects on the sexual,
thoughts, feelings and behavior of people and that these eﬀects may be
positive and negative.
The aforementioned ﬁndings raise the question whether positive or
negative associations between substance use and sexual functioning or
sexual behavior can also be found among people who receive treatment
for their use of substances. This question is important because the
perceived relationship between substance use and sexuality may play a
role in the eﬀect of treatment for substance use. It may be diﬃcult to
abstain from substances if the patient considers sex under the inﬂuence
of a psychoactive agent to be more rewarding than sober sex or if the
patient experiences that abstaining from the substance negatively im-
pacts their sexual desire or pleasure. In this respect, it has been stated
that “without any scientiﬁc knowledge about the connection between
substance use and sexual behavior, treatment of patients who experi-
ence a strong drugs-sex connection is based on myths and speculations”
(Rawson et al., 2002, p. 104).
Being diagnosed with a DSM-IV alcohol dependence is associated
with signiﬁcantly increased odds of being a regular presex drinker
(Eaton et al. (2015). In addition it has been found that adults in sub-
stance use treatment commonly report combining sex and alcohol or
drugs at their most recent sexual event (Calsyn et al., 2010). These
studies only looked into the prevalence of sex under the inﬂuence
within the population and the association with high-risk sexual beha-
vior, not in to the association or relation between substance use and
sexual behavior. In one of the rare studies regarding this topic in a
population of patients with a substance use disorder, Rawson et al.
(2002) found that diﬀerent categories of drugs were associated with
diﬀerent reported eﬀects on sexual behavior. Methamphetamine users
reported an increase of sexual thoughts, behaviors and activity. Cocaine
users also reported a positive, but weaker relationship between the use
of cocaine and their sexual behavior. Alcohol users reported an even
weaker association. Furthermore, opiate users reported virtually no
relationship between the use of drugs and their sexual behaviors Un-
fortunately, Rawson et al. (2002) looked only into enhancement in
sexual thoughts, feelings and behavior under the inﬂuence of a sub-
stance and not into negative eﬀects of drug use on sexual thoughts,
feelings and behavior. This is unfortunate because, as shown, studies in
the general population have shown positive as well as negative eﬀects
of drug use on sexual functioning and behavior. In addition, Rawson
et al. (2002) addressed only the perceived eﬀect of a substance which
leaves it uncertain whether there were also actual changes in sexual
behavior (i.e. more frequent sexual activity, more sexual partners, more
risky sexual behavior, etc.) or whether these sexual behaviors diﬀered
between the diﬀerent type of drug users.
In line with Rawson et al. (2002), a few other studies in patient
samples found that (meth)amphetamine users endorse primarily posi-
tive associations between drug use and sexual thoughts, feelings and
behavior (Hamilton Brown, Domier, & Rawson, 2005; Isa et al., 2013;
Skarner & Svensson, 2013). In addition, patients with a cocaine use
disorder have been found to report both positive and negative eﬀects of
drug use on sexual functioning and behavior (Hamilton Brown et al.,
2005; Kopetz et al., 2010). However, these studies, too, focused mainly
on a perceived sexual eﬀect of the substance and did not address actual
sexual behaviors.
The purpose of the current study was to further examine perceived
sexual eﬀects of drug use and actual sexual behavior in patients with a
substance use disorder. Because patients may perceive positive asso-
ciations between their substance use and the perceived sexual func-
tioning as well as negative associations, both types of associations were
addressed in the present study in addition to associations with risky
sexual behaviors. These perceived associations and behaviors were
studied in four types of patients: users of alcohol, stimulants (i.e. am-
phetamine, cocaine), sedatives and GHB.
Building on the work of Rawson et al. (2002), we hypothesized that
patients with a stimulant use disorder experience more positive eﬀects
of the use of the substance on their sexual thoughts, feelings and be-
haviors than do patients with an alcohol use disorder, who in turn ex-
perience more positive eﬀects than do patients with a sedative use
disorder. We did not have speciﬁc hypotheses with regard to diﬀerent
experienced negative eﬀects in these groups of patients, so these
eventual diﬀerences were explored. In addition, we explored the sexual
activity and behavior (e.g. number of sexual partners, sexual activity) of
patients with a substance use disorder and compared these variables
among the four subgroups.
2. Method
2.1. Participants
The participants in this study were patients (N=208) with a DSM-
IV-tr (APA, 2000) substance use disorder who had enrolled in one of the
inpatient or outpatient treatment programs at a specialized institution
for addiction care in the North of the Netherlands (Verslavingszorg
Noord Nederland).
Inclusion criteria for participation were having a DSM-IV-tr sub-
stance abuse disorder (alcohol, amphetamine, cannabis, cocaine, GHB
or opiates) as the primary diagnoses, being at least 23 years of age and
being abstinent at the moment of admission. It was decided not to in-
clude patients who had been abstinent for more than six months at the
time of sampling and patients who had experienced a psychotic episode
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or had displayed suicidal ideations in the previous month. The use of
more than one substance was allowed only when the participant was
able to clearly identify one substance as their primary drug of abuse.
From the 208 participants who gave their informed consent, 180
ﬁlled in the survey. Reasons for withdrawal were reconsidering parti-
cipation or not replying on requests to start the assessment. Participants
(N=180) met the diagnostic criteria for DSM-IV-tr (APA, 2000) for
abuse or dependence of alcohol, amphetamine, cannabis, cocaine, GHB
or opiates as the primary diagnosis. 31% of the participants were
treated in an inpatient treatment-program, whilst 69% received out-
patient treatment.
To ensure the sample to closely resemble a usual patient sample,
participants were divided into diﬀerent groups according to what they,
themselves, registered in the Substance Use and Sexual Behavior
questionnaire (SUSBQ) as their reported primary drug of abuse or de-
pendence: alcohol (N=73), stimulant (i.e. cocaine (N=31) or am-
phetamine (N=15)), sedative (i.e. cannabis (N=24) or opiates
(N=22)) and GHB (N=15). A total of 64% used another substance
besides their primary substance of abuse or dependence. This dis-
tribution of primary substance was representative for all SUD patients
in Dutch addiction mental health care institutions (see Wisselink,
Kuijpers, and Mol (2016) for the Dutch national statistics on patients),
with the exception of patients with the misuse of amphetamine (8% in
the sample vs 3% in the entire population) and GHB (8% vs 1%). These
two types of patients were overrepresented in the sample due to the
extra eﬀort of having suﬃcient numbers of such users in the sample,
whereby the original intention based on power analysis was to have at
least 39 patients in each group.
Of the respondents, 69% were male and the mean age of the par-
ticipants was 40.20 years (SD=11.52 years, age range 19–71). As such,
the sample was representative for all SUD patients in Dutch addiction
mental health care institutions with regard to gender (76% male) and
age (M=42 years). 41% had a relationship. Sexual orientation was
reported by 85% as heterosexual, 4% as gay/lesbian and 11% as bi-
sexual.
2.2. Instruments
The Substance Use and Sexual Behavior questionnaire (SUSBQ) is a
self-constructed 69-item survey that was adapted from the instrument
that was constructed by Rawson et al. (2002). The SUSB has six back-
ground questions (age, gender, education level, ethnicity, relationship
status, residence), six questions about substance use (e.g., primary
substance of abuse, use of other substances, substance use in the pre-
vious thirty days, use of medication), twenty-nine questions about
sexual behavior (e.g. sexual experience, number of sexual partners,
sexual frequency, same sex sexuality, masturbation, sexual explicit
media use and sex on or through the internet (i.e. webcam sex, dating
via internet), sexual daydreaming/fantasies, sexual dysfunction) and
three questions about treatment history (for substance use disorder and
other psychopathology). In addition, the SUSB has 25 statements about
the perceived changes in sexual thoughts, feelings and behavior under
inﬂuence of the primary substance of abuse that require an answer on a
5-point scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Of
the 25 statements, six items addressed the perceived enhancement of
sexual drive, sexual pleasure, sexual performance, sexual interest/ob-
session and unusual sexual behavior. These six items were combined to
form the ‘Perceived enhancement’ scale, which counts the number of
perceived enhancements, ranging from 0 (no reported enhancement) to 6
(six reported enhancements). In addition, the two items on perceived
relationship with risky sexual behavior and occasional sexual behavior
(i.e. ‘I am more likely to practice “risky” sex under the inﬂuence of my
primary drug of abuse’ and ‘I have become involved in sex acts that are
unusual for me when I am under the inﬂuence of my primary substance
of abuse’) were combined to form the ‘Perceived risk’ scale, which
counts the number of perceived risks, ranging from 0 (no reported
change in risky behavior) to 2 (two reported changes in risky behavior).
Finally, the six items about perceived decline in sexual drive, sexual
pleasure, sexual performance, sexual interest/obsession, sexual beha-
vior (frequency and inhibition) were combined to form the ‘Perceived
decline’ scale, which counts the number of perceived declines, ranging
from 0 (no decline) to 6 (six reported decrements). All three scales had
adequate test-retest reliability after one week (0.69 < r < 0.86) and
good internal consistency (Cronbach's alphas at least 0.84).
The severity of the substance use disorder and the DSM-IV-tr diag-
nosis were based on the Measurements of the Addiction for Triage and
Evaluation (MATE: Schippers, Broekman, & Buchholz, 2011). Con-
ceptually, the MATE was constructed according to the ICD and Inter-
national Classiﬁcation of Functioning (ICF) in the World Health Orga-
nization (WHO) classiﬁcation system). The instrument consists of ten
components that explore, among others, current problematic substance
abuse and history of drug use, history of healthcare, somatic com-
plaints, as well as social and environmental support networks. It as-
sesses the diagnoses dependence and abuse according to the DSM-IV-tr.
The MATE yields 20 sum scores, which can be summarized into four
dichotomized so-called dimension scores: Addiction severity, severity of
psychiatric co-morbidity, severity of social disintegration, and history
of treatment for substance-use disorder. The MATE is considered to
have a good inter-rater reliability, which shows to be better with more
training in administering the MATE (Schippers et al., 2011), and ade-
quate validity when compared to the World Health Organization Dis-
ability Assessment Schedule (WHODAS) (Schippers & Broekman,
2007).
2.3. Procedure
Prior to the start of this study, the research proposal was reviewed
and approved by the Medical Ethical Committee of the University
Medical Center Groningen (UMCG) in accordance with the 1999 Dutch
Law on Medical Scientiﬁc Research involving Human Beings. The study
was conducted from January 2016 until June 2017 in ﬁve outpatient
clinics and two inpatient clinics of the institution.
Patients were asked for their participation after their intake. Extra
eﬀort was made to include patients with an amphetamine use disorder,
cocaine use disorder and GHB use disorder to create groups of about
equal size.
During the intake, the MATE (Schippers, Broekman, Buchholz,
Koeter & van den Brink, 2010) was administered by trained profes-
sionals, to acquire information about the severity of the substance
abuse and the DSM-IV-tr classiﬁcation. Based on the information de-
rived from the MATE and the admission intake, chartered (clinical)
psychologist, masters in addiction medicine or psychiatrists determined
the DSM-IV-tr classiﬁcation of a substance abuse or dependence dis-
order.
Before ﬁlling in the questionnaire ‘Substance Use and Sexual
Behavior’ (SUSB), patients were asked to give written informed consent.
Participation was voluntary and conﬁdential. Participants could ﬁll in
the SUSB in the presence of one of the researchers or online on a se-
cured website.
2.4. Statistical analyses
The ﬁrst aim of this study was to compare perceived associations
between the use of substances and sexual thoughts, feelings and be-
havior across four groups of patients with a substance use disorder (i.e.
alcohol, sedatives, stimulants, GHB). For this purpose the three scales
(i.e. Perceived enhancement, Perceived decline, Perceived risk) were
created. A MANOVA analysis, using Pillai's trace, was employed to
compare the total scores of the three dependent variables across the
four groups and to control for answering tendency between the de-
pendent variables. Pillai's trace was chosen since this test is considered
to be the most powerful and robust statistic for general use.
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In order to test the hypothesis that patients with a stimulant use
disorder experience more positive eﬀects of the use of the substance on
their sexual thoughts, feelings and behavior than do patients with an
alcohol use disorder, who in turn experience more positive eﬀects than
do patients with a sedative use disorder, the mean score on the
Enhancement scale was compared across the four groups using a
ANOVA analysis. A Games-Howell post-hoc test of pairwise comparison
was conducted to elucidate which group diﬀered signiﬁcantly from
other groups. Games-Howell post-hoc test was chosen, because it does
not assume equal sample sizes and variances. We chose not to add
preplanned contrasts to the analyses, since GHB was added as an extra
group and no scientiﬁc information was available about GHB users
experience more or less positive eﬀects of the use of the substance than
the other groups of substances. In addition, the same analyses were
conducted on the other two scales (Perceived decline, Perceived risk) to
compare the diﬀerent mean scores across the four groups.
The second aim of this study was to explore the actual sexual be-
havior of patients with a substance use disorder and to compare these
behaviors across the four subgroups. To compare the sexual behavior in
the previous six months (e.g. number of sexual partners, frequency of
sexual encounters, frequency of masturbation) between the four groups,
non-parametic tests (Kruskal-Wallis test) and chi-square analyses were
conducted. Levene's test of homogeneity showed that the variance of
equality for the number of sex partners in the previous six months was
unequal (F(3, 176)= 12.85, p < .001). This meant that a Kruskal-
Wallis test needed to be conducted to compare the number of sex
partners in the previous six months across the four groups. To elucidate
which group diﬀered signiﬁcantly from the other groups additional
Mann-Whitney tests were conducted, using a Bonferroni correction for
multiple comparisons.
For all the analyses pairwise deletion of cases were used for hand-
ling missing data.
3. Results
All four groups reported perceived changes in sexual thoughts,
feelings and behavior due to the use of their primary substance. Of the
total sample 59.4% reported enhancements in at least one sexual do-
main (i.e. sexual drive, sexual pleasure, sexual performance, sexual
interest/obsession and unusual sexual behavior.) (M=1.80 changes,
SD=1.92 changes) and 60.6% reported decrement in at least one
sexual domain (M=1.61 changes, SD=1.88 changes). In addition,
50.6% of the total sample reported at least one change in risky sexual
behavior (M=0.82 changes, SD=0.89 changes).
Of the total sample 23.3% stated that their sexual thoughts, feelings
and behaviors were often associated with the use of their primary
substance of abuse. In addition, 11.4% of the participants stated that
they experienced such a strong association between sex and substance
use that they encountered diﬃculties in separating drug use from their
sexual behavior. Furthermore, 9.7% of the participants stated that
sexual thoughts and feelings cause craving and 9.1% of the participants
felt that they needed treatment for their sexual behavior as they felt
that it was linked to the use of their primary substance of abuse.
Of the participants 27% reported that they had had two or more
sexual partners in the previous six months, 24.0% reported having sex
at least a few times every week in the past six months, and 43.9% re-
ported to masturbate at least once a week. In addition 31.7% of the
participants used pornography weekly or more often, 5.6% reported to
participate in cybersex (i.e. webcam sex, sex-chatting) and 16.7% stated
having had sexual encounters via the Internet in the past six months.
3.1. Perceived changes in sexual thoughts, feelings and behavior due to
substance use in the four groups
A MANOVA analysis, using Pillai's trace, revealed that the three
perceived changes scales diﬀered signiﬁcantly between the four patient
groups (V=0.23, F(3, 174)= 4.91 p < .001) (see Table 1). Following
ANOVAs of the scales revealed signiﬁcant diﬀerences on the mean
scores of Perceived enhancement (F(3, 176)= 11.78, p < .001), Per-
ceived decline (F(3, 176)= 4.12, p < .01) and Perceived risk (F(3,
176)= 3.92, p < .001). Post-hoc tests of pairwise comparison using
the Games-Howell post hoc criterion showed that GHB patients and
patients who used stimulants perceive signiﬁcantly more sexual en-
hancement than did patients that used alcohol or sedatives (both
p < .05). No signiﬁcant diﬀerences on the Perceived enhancement
scale were found between GHB patients and patients that used stimu-
lants, and between patients that used alcohol and patients that used
sedatives.
With regard to the reporting of perceived sexual decline the GHB
group perceived less decline than did the other three groups of patients
(all p < .05). No further signiﬁcant diﬀerences were found on the
Perceived decline scale.
Similar analyses revealed that patients that used GHB reported
signiﬁcantly more perceived risky sexual behavior than did patients
that used a sedative (p < .05). In addition, patients that used a sedative
reported signiﬁcantly less perceived risky sexual behavior than did
patients that used alcohol (p < .05). No further signiﬁcant diﬀerences
were found on the Perceived risk scale.
3.2. Other perceived associations in the four groups
Chi square analyses revealed that the four groups did not diﬀer with
regard to the percentages of patients reporting about a self-perceived
association between sexual thoughts, feelings and behaviors and the use
of their primary substance of abuse (χ2 (3)= 3.76, ns), sexual thoughts
and feelings causing craving (χ2 (3)= 5.82, ns), the need for treatment
for their sexual behavior (χ2 (3)= 6.64, ns). Similar analyses revealed a
signiﬁcant diﬀerence between the groups regarding experiencing dif-
ﬁculties in separating drug use from their sexual behavior (χ2
(3)= 9.09, p < .05). None of the users of a sedative stated that they
experienced a diﬃculty in separating the use of their primary substance
from their sexual behavior. This percentage was signiﬁcant lower than
for the other three groups (all χ 2(1) > 6.18, all p < .005).
3.3. Actual sexual behavior and activity in the four groups
The patient groups diﬀered from each other in their sexual behavior
and activity in the six months before assessment (see Table 2). For a
start, a Kruskal-Wallis test revealed that the mean number of sexual
partners in the past six months diﬀered signiﬁcantly between the four
groups (H (3)= 18.29, p < .01). Additional Mann-Whitney tests
showed that the mean number of sexual partners was signiﬁcantly
lower for patients that used alcohol than for the patients that used
stimulants (U=1060.0, r=−0.33, p < .01) or GHB (U=288.5,
r=−0.33, p < .01). Similar analyses revealed diﬀerences in the
Table 1
Mean scores, standard deviation on the number of perceived changes scales in
sexual functioning for users of alcohol (N= 73), sedatives (N=46), stimulants
(N= 46) and GHB (N=15).








1.62a (1.83) 2.15a (2.12) 1.48a (1.79) 0.27b
(0.46)
Perceived risk M (SD) 0.90a (0.92) 0.46b (0.71) 0.87a,b (0.86) 1.40a
(0.83)
Note. Means in a row sharing a subscript are not signiﬁcantly diﬀerent at
α=0.05, based on Games-Howell post hoc analyses;M=mean; SD=standard
deviation.
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frequency of sexual contact with a partner in the past six months (H
(3)= 10.42, p < .05), with users of stimulants (U=1216.5,
r=−0.24, p < .001) and users of GHB (U=326.5, r=−0.27,
p < .05) being signiﬁcantly more sexually active than users of alcohol.
Furthermore, chi-square analysis showed a signiﬁcant diﬀerence be-
tween the four groups with regard to the percentage of having more
than two sexual partners in the previous six months (χ2(6)= 24.54,
p < .001). In this respect, the percentage of patients that used GHB
was signiﬁcantly higher than the percentage of patients that used al-
cohol or sedatives. (8.95 < χ2 (2) < 15.76, both p < .01).
With regard to the frequency of masturbation in the past six months
a signiﬁcant diﬀerence was found between the four groups (H
(3)= 8.31, p < .05). Patients using stimulants reported a signiﬁcantly
higher frequency of masturbation than did patients using alcohol
(U=1215.0, r=−0.24, p < .001). Furthermore, the frequency of
sexual encounters via the Internet diﬀered between the four groups of
patients (H (3)= 8.80, p < .01), with users of GHB stating that they
more often had had sexual encounters via the Internet than had users of
alcohol (U=380.0, r=− 0.33, p < .01). There were no signiﬁcant
diﬀerences between the groups of users in the use of porn (H
(3)= 0.08, ns) and frequency of cybersex (H(3)= 2.05, ns).
4. Discussion
The results clearly show that there is a relationship between the use
of a psychoactive substance and sexual behavior within a population of
patients with a substance use disorder. For a start, about a quarter of
participants stated that their sexual thoughts, feelings, and behaviors
were often associated with their primary substance. In addition, about
one in every ten patients stated that sexual thoughts and feelings caused
craving for the primary substance of abuse and about an equal number
believed that they would experience diﬃculties separating the use of
substance from their sexual behavior due to the association.
Furthermore, about one in every ten patients stated that they needed
treatment for their sexual behavior as it was linked to the use of their
primary substance of abuse. Furthermore, a substantial percentage of
patients with a substance use disorder reported perceived changes in
sexual thoughts, feelings and behavior due to the use of their primary
substance of abuse. Almost 60% reported that they experienced en-
hancements in several sexual domains (i.e. sexual arousal, sexual
pleasure, sexual performance, sexual behavior) after using their pri-
mary substance of abuse. About equal numbers reported decrements in
the diﬀerent sexual domains (i.e. sexual arousal, sexual pleasure, sexual
performance, sexual behavior) under the inﬂuence of a substance and
more than half reported more risky sexual behaviors in this situation.
Because all these percentages are high and in line with results from
previous studies (Hamilton Brown et al., 2005; Isa et al., 2013; Skarner
& Svensson, 2013; Rawson et al., 2002), it can be concluded that sub-
stance use and sexual thoughts, feelings and behavior are related to
each other in the minds of many patients with a substance use disorder.
The ﬁndings also show that the relationship between substance use
and perceived sexual thoughts, feelings and behavior diﬀers between
diﬀerent groups of patients. As expected (see also Rawson et al., 2002),
patients using stimulants are found to experience more enhancements
than do patients using alcohol, but these in turn are not found to ex-
perience more enhancements than do patients using sedatives. This
ﬁnding appears to be at odds with other studies (Isa et al., 2013; Kopetz
et al., 2010; Rawson et al., 2002), but can be explained by the fact that
the present study combined users of opiates with users of cannabis.
Additional analyses, comparing patients that used alcohol with patients
that used opiates revealed the expected diﬀerences, because the patient
group that used alcohol showed signiﬁcantly more perceived en-
hancements in sexual functioning, less perceived decrement and more
perceived risky sexual behavior than did the patient group that used an
opiate.
Especially users of GHB and stimulants appear to experience more
enhancements in sexual domains (e.g. sexual pleasure, sexual arousal,
sexual performance) under the inﬂuence of the substance than do users
of alcohol and sedatives. With regard to stimulants, this is in line with
ﬁndings from previous studies (Hamilton Brown et al., 2005; Isa et al.,
2013; Kopetz et al., 2010; Rawson et al., 2002; Skarner & Svensson,
2013), but GHB stands out even more as a substance with a strong
relationship with perceived and actual sexual behaviors. Users of GHB
not only reported more enhancement in sexual domains, but also less
decline in sexual domains, more sexual partners in the previous months,
a higher frequency of sexual encounters and more often sexual en-
counters via the Internet than did patients using alcohol, sedatives and
stimulants. In addition, users of GHB reported more perceived risky
behavior than did users of sedatives. In our knowledge, this is the ﬁrst
study that shows that patients of a GHB use disorder experience such a
strong relationship between the use of GHB and sexual thoughts, feel-
ings and behavior. Nonetheless, some caution is in place because of the
small sample of GHB users. Small sample sizes are more likely to pro-
duce inﬂated eﬀect sizes.
Compared to the users of other psychoactive agents, users of alcohol
were found to be less sexually active (i.e. less number of sexual part-
ners, lower frequency of sexual encounters and masturbation), despite
the fact that they reported more risky behaviors after using alcohol than
did users of a sedative. Thus, there appears to be a diﬀerence between
the actual sexual activity and the reporting of a relationship between
the use of alcohol and the sexual behavior. For the entire group of
patients, more than half reported perceived changes in sexual thoughts,
feelings and behavior under the inﬂuence of a substance, whilst only a
quarter reported an association between sexual thoughts, feelings and
behavior and substance use. This diﬀerence may be explained by an
impaired (self) insight and awareness that is often found in patients
with a substance use disorder (Probs, Manthey, Martinez, & Rehm,
2015; Stoddard Dare & Derigne, 2010).
With regard to actual sexual activity it strikes out that patients with
a substance use disorder appear to be quite sexually active in com-
parison to the Dutch general population (see de Graaf (2012) for sta-
tistics in the Dutch population) as they more often had two or more
sexual partners in the previous six months, more often reported about
masturbating weekly or more, and more often reported about using
pornography weekly or more. These ﬁndings again stipulate that sub-
stance abuse and sexual functioning and behavior are related to each
other.
There may be three explanations for the relation between substance
use and sexual behavior. Firstly, there may be a direct causal relation
between the use of the substance and the sexual behavior due to the
(psycho)pharmacological eﬀects of the psychoactive agent, whereby
the substance use enhances or inhibits sexual functioning, sexual
Table 2
Sexual behaviors in the previous six months for users of alcohol (N= 73), sti-
mulants (N= 46), sedatives (N=46) or GHB (N=15).
Variable Alcohol Sedatives Stimulants GHB
Mean number of sexual
partners (SD)
0.89a (1.20) 1.59a,b (2.80) 1.76b (1.61) 3.93b
(5.80)
% relationship 60.3 55.6 56.5 73.3
% >2 sexual partners 13.7a 19.6a,b 43.5b,c 60.0c
% >weekly sexual
contact
21.9a 34.7a,b 32.6b 60.0a,b
% >weekly
masturbation
47.9a 45.6a,b 69.5b 60.0a
% >weekly use of porn 30.1 36.9 28.2 33.3
% cybersex 2.7 6.5 8.7 6.7
% sex via internet 11.0a 15.2a,b 19.6a,b 40.0b
Note. Means in a row sharing a subscript are not statistically diﬀerent at
α=0.01, using a Bonferroni correction for multiple comparison. No subscript
within a row means no signiﬁcant diﬀerence at α=0.05 between the groups;
SD=standard deviation.
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pleasure and arousal and delays or hampers orgasm (Gianotten, 2009;
McKay, 2005; Miller & Gold, 1988; Nicholson & Balster, 2001; Peugh &
Belenko, 2001; Washton & Zweben, 2006). Secondly, an indirect rela-
tion may exist because underlying factors may contribute to substance
use as well as sexual behavior, such as less self-control, sensation
seeking, and other biological, neurocognitive, psychological or social
factors (see, Bornovalova, Lejuez, Daughters, Rosenthal, & Lynch, 2005,
Caspi et al., 1997, Henderson, Galen, & DeLuca, 1998, Krueger et al.,
2002). Thirdly, the nature of the relationship may be interpreted by the
lifestyle that is associated with the (mis)use of a certain psychoactive
agent, whereby the lifestyle also includes a higher exposure to sexual
opportunities.
In the present sample, most participants reported multiple substance
use, especially patients that used GHB (87%), implying that the re-
lationship between sexual behavior and substance use may be due to
underlying factors or a certain lifestyle associated with the use of a
certain psychoactive agent, because multiple substance use is often
associated with factors such as impulsivity, risk-taking behavior and
sensation seeking (Henderson et al., 1998). These factors are part of the
transdiagnostic factor externalization as proposed by Krueger, McGue,
and Iacono (2001). Rodriguez-Seijas, Arfer, Thompson Jr, Hasin, and
Eaton (2017) found a close association between sex-related substance
use and the externalization spectrum.
Additional analyses on groups of patients reporting single drug use
only, showed roughly the same (but not statistically signiﬁcant) results,
implying that the eﬀects may be attributed to some extent to the
pharmacological eﬀect of the substance. However, because these fur-
ther analyses were based on small sample sizes and because they
yielded non-signiﬁcant diﬀerences, no conclusions can be drawn from
these further analyses. Future research is needed to understand the
relationship between substance use and sexual behavior in patients
with a substance use disorder and to explain the diﬀerences found be-
tween the groups of patients.
4.1. Limitations
The ﬁndings have to be considered with some concern about va-
lidity and generalizability because of the use of a new instrument that
has not been further tested on validity. The reliability (both test-retest
reliability as internal consistency) of the instrument showed to be fair to
good, but less is known about whether answers were biased by recall
bias, social desirability or fantasy. Herewith, it would be advisable to
further test the validity of the instrument to measure the relationship
between substance use and sexual thoughts, feelings and behavior.
In addition, the present study did not address diﬀerences between
patients in inpatient treatment and patients in outpatient treatment,
leaving questions about generalizability. Future research should ad-
dress gender and sexual orientation as inﬂuencing factors, because
studies have found gender diﬀerences in the prevalence of pre-sex
substance use (Eaton et al. (2015) and the perceived relation between
substance use and sexual thoughts, feelings and behavior (Rawson et al.
(2002). Gilbert, Trocki, and Drabble (2015) showed that sexual min-
ority men and women reported more presex drinking than did their
same-gender heterosexual peers, showing that sexual orientation needs
to be considered as an inﬂuencing factor. Furthermore, the present
study consisted of only a few users of GHB, whereby the small sample
size caused some heterogeneity of variance and may have caused, as
mentioned, inﬂated eﬀect size. In our opinion, this did not jeopardize
the ﬁndings because additional non-parametic analyses showed an even
stronger relationship between sexual behavior and drug use among the
users of GHB. However, future research is needed to corroborate these
ﬁndings. Future research needs also to look further into the diﬀerences
in perceived and actual sexual thoughts, feelings and behavior between
diﬀerent psychoactive agents within one category of substances (e.g.
sedatives). Furthermore, future research could investigate other ways of
dividing a patient sample in categories of primary substance of use. In
the present study, the categorization was made according to the per-
ceptions of the patients themselves.
4.2. Implications
Altogether, this study clearly ﬁnds a relationship between the use of
substances and perceived and actual sexual behaviors among patients
with a substance use disorder. This underlines the importance of ad-
dressing the relationship in treatment programs, as patients may be
hesitant to stop their use of substances when they experience many
positive eﬀects in their sexual behavior.
Better understanding of the relationship between substance use and
sexual behavior may allow treatment providers to educate patients who
experience a strong connection between their substance use and their
sexual behavior. In addition, better understanding may promote treat-
ment strategies to be developed to help patients to handle drugs-sex
related situations during recovery. Furthermore, it seems wise to ex-
amine a patient's sexual behavior needs in order to know which speciﬁc
sexual issues may undermine recovery. The present study indicates that
sexuality needs to be addressed within treatment programs.
Speciﬁcally, treatment interventions need to be developed to help dis-
connecting the link between substance use and sexual thoughts, feelings
and behavior and debilitating the associations between these two, so
that they are more manageable to patients. In our opinion, it is im-
portant that practitioners acknowledge the relationship between sub-
stance use and sexual behavior and address sexuality in order to im-
prove treatment outcomes for patients with substance use disorders.
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